CRISPR-tiling screening revealed that H3K4 methylation modifiers have a non-redundant function with the SETD1A SET domain in AML (Fig. 1B, Supplementary Fig. 1F). The gene discussed is SETD1A; the disease is acute myeloid leukemia.